-transparent.png){kind=logo}
The aim of this study was to determine the incidence of fungal infections detected on autopsy in a group of 40 patients with hematologic malignancies treated with intensive chemotherapy or bone marrow transplantation, and to evaluate the risk factors for fungal infections. A control group included 38 patients with nonhematologic diseases and without granulocytopenia but with at least one of the known risk factors for fungal infections. Standard histopathological and microbiological methods were used. A higher incidence of invasive fungal infections was found in patients with hematologic malignancies as compared to the control group (p < 0.01). The predominant causes of fungal infections were Candida albicans and Aspergillus spp. The incidence of fungal infections caused by Aspergillus was higher (p < 0.05) in patients with hematologic malignancies than in the control group. The independent risk factors for fungal infections were fungal colonization, number of antibiotics and duration of antibiotic therapy, duration of fever and skin rash. A higher proportion of fungal infections was diagnosed on autopsy than during the patients' life (p < 0.01).
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
June 1994,
Medizinische Klinik (Munich, Germany : 1983),
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
January 2000,
Antibiotics and chemotherapy,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
December 2002,
Infectious disease clinics of North America,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
January 1999,
Chemotherapy,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
April 2012,
Zhongguo shi yan xue ye xue za zhi,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
January 1986,
Hematological oncology,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
August 2006,
Haematologica,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
October 2004,
Supportive cancer therapy,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
May 1990,
Indian journal of medical sciences,
M Jandrlić, and
S Kalenić, and
B Labar, and
D Nemet, and
J Jakić-Razumović, and
M Mrsić, and
V Plecko, and
V Bogdanić
July 2006,
Haematologica,
